Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
SP3
|
ENSG00000172845.9 | Sp3 transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
SP3 | hg19_v2_chr2_-_174828892_174828972 | 0.21 | 2.7e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chrY_+_22737678 | 4.95 |
ENST00000382772.3
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
chr10_+_135192695 | 4.88 |
ENST00000368539.4
ENST00000278060.5 ENST00000357296.3 |
PAOX
|
polyamine oxidase (exo-N4-amino) |
chr10_+_11784360 | 4.51 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
chr10_+_135192782 | 4.33 |
ENST00000480071.2
|
PAOX
|
polyamine oxidase (exo-N4-amino) |
chrY_+_22737604 | 3.77 |
ENST00000361365.2
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
chr2_+_95691417 | 3.75 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
chrX_+_30671476 | 3.63 |
ENST00000378946.3
ENST00000378943.3 ENST00000378945.3 ENST00000427190.1 ENST00000378941.3 |
GK
|
glycerol kinase |
chr1_+_211432775 | 3.53 |
ENST00000419091.2
|
RCOR3
|
REST corepressor 3 |
chr2_+_95691445 | 3.32 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
chr17_-_76183111 | 3.29 |
ENST00000405273.1
ENST00000590862.1 ENST00000590430.1 ENST00000586613.1 |
TK1
|
thymidine kinase 1, soluble |
chr16_-_87903079 | 3.26 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
chr3_-_50340996 | 3.08 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr12_-_95044309 | 3.03 |
ENST00000261226.4
|
TMCC3
|
transmembrane and coiled-coil domain family 3 |
chr11_-_45687128 | 2.97 |
ENST00000308064.2
|
CHST1
|
carbohydrate (keratan sulfate Gal-6) sulfotransferase 1 |
chr19_-_14201507 | 2.92 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr6_-_4135693 | 2.86 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr11_-_2160611 | 2.81 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr14_+_105941118 | 2.78 |
ENST00000550577.1
ENST00000538259.2 |
CRIP2
|
cysteine-rich protein 2 |
chr6_-_4135825 | 2.70 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
chr2_+_172378757 | 2.70 |
ENST00000409484.1
ENST00000321348.4 ENST00000375252.3 |
CYBRD1
|
cytochrome b reductase 1 |
chr2_-_241396131 | 2.65 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr11_-_2160180 | 2.65 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chrX_+_38420623 | 2.63 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chrY_+_15016725 | 2.62 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr21_-_44496441 | 2.61 |
ENST00000359624.3
ENST00000352178.5 |
CBS
|
cystathionine-beta-synthase |
chr21_-_44495919 | 2.61 |
ENST00000398158.1
|
CBS
|
cystathionine-beta-synthase |
chr8_+_124428959 | 2.57 |
ENST00000287387.2
ENST00000523984.1 |
WDYHV1
|
WDYHV motif containing 1 |
chr4_-_819880 | 2.55 |
ENST00000505203.1
|
CPLX1
|
complexin 1 |
chr3_-_53290016 | 2.46 |
ENST00000423525.2
ENST00000423516.1 ENST00000296289.6 ENST00000462138.1 |
TKT
|
transketolase |
chr11_+_45944190 | 2.45 |
ENST00000401752.1
ENST00000389968.3 ENST00000325468.5 ENST00000536139.1 |
GYLTL1B
|
glycosyltransferase-like 1B |
chr12_+_50355647 | 2.44 |
ENST00000293599.6
|
AQP5
|
aquaporin 5 |
chr12_-_51785182 | 2.44 |
ENST00000356317.3
ENST00000603188.1 ENST00000604847.1 ENST00000604506.1 |
GALNT6
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) |
chr22_-_37915247 | 2.42 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
chr11_-_119187826 | 2.42 |
ENST00000264036.4
|
MCAM
|
melanoma cell adhesion molecule |
chr4_-_819901 | 2.40 |
ENST00000304062.6
|
CPLX1
|
complexin 1 |
chr22_+_42949925 | 2.37 |
ENST00000327678.5
ENST00000340239.4 ENST00000407614.4 ENST00000335879.5 |
SERHL2
|
serine hydrolase-like 2 |
chrX_+_38420783 | 2.36 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr18_+_11981547 | 2.34 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chrX_-_134232630 | 2.32 |
ENST00000535837.1
ENST00000433425.2 |
LINC00087
|
long intergenic non-protein coding RNA 87 |
chr18_+_11981427 | 2.30 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr7_-_75368248 | 2.25 |
ENST00000434438.2
ENST00000336926.6 |
HIP1
|
huntingtin interacting protein 1 |
chr14_+_94640633 | 2.21 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
chr2_-_160761179 | 2.18 |
ENST00000554112.1
ENST00000553424.1 ENST00000263636.4 ENST00000504764.1 ENST00000505052.1 |
LY75
LY75-CD302
|
lymphocyte antigen 75 LY75-CD302 readthrough |
chr5_+_612387 | 2.17 |
ENST00000264935.5
ENST00000444221.1 |
CEP72
|
centrosomal protein 72kDa |
chr2_+_85811525 | 2.15 |
ENST00000306384.4
|
VAMP5
|
vesicle-associated membrane protein 5 |
chr5_-_60140009 | 2.15 |
ENST00000505959.1
|
ELOVL7
|
ELOVL fatty acid elongase 7 |
chr21_-_44495964 | 2.14 |
ENST00000398168.1
ENST00000398165.3 |
CBS
|
cystathionine-beta-synthase |
chr18_+_11981014 | 2.13 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr7_-_148580563 | 2.12 |
ENST00000476773.1
|
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
chr11_-_2158507 | 2.10 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr14_+_100070869 | 2.09 |
ENST00000502101.2
|
RP11-543C4.1
|
RP11-543C4.1 |
chr12_-_120315074 | 2.08 |
ENST00000261833.7
ENST00000392521.2 |
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
chr5_-_9546180 | 2.08 |
ENST00000382496.5
|
SEMA5A
|
sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A |
chr2_-_197036289 | 2.07 |
ENST00000263955.4
|
STK17B
|
serine/threonine kinase 17b |
chr14_-_23834411 | 2.07 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr13_-_20806440 | 2.05 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
chr7_-_143059780 | 2.04 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr16_-_90085824 | 2.04 |
ENST00000002501.6
|
DBNDD1
|
dysbindin (dystrobrevin binding protein 1) domain containing 1 |
chr10_-_135150367 | 2.04 |
ENST00000368555.3
ENST00000252939.4 ENST00000368558.1 ENST00000368556.2 |
CALY
|
calcyon neuron-specific vesicular protein |
chr3_-_128840604 | 2.03 |
ENST00000476465.1
ENST00000315150.5 ENST00000393304.1 ENST00000393308.1 ENST00000393307.1 ENST00000393305.1 |
RAB43
|
RAB43, member RAS oncogene family |
chr20_+_37554955 | 2.03 |
ENST00000217429.4
|
FAM83D
|
family with sequence similarity 83, member D |
chr12_-_125348329 | 2.02 |
ENST00000546215.1
ENST00000415380.2 ENST00000261693.6 ENST00000376788.1 ENST00000545493.1 |
SCARB1
|
scavenger receptor class B, member 1 |
chr7_-_150780487 | 2.02 |
ENST00000482202.1
|
TMUB1
|
transmembrane and ubiquitin-like domain containing 1 |
chr6_+_80714318 | 2.02 |
ENST00000369798.2
|
TTK
|
TTK protein kinase |
chr19_-_55658687 | 2.01 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr12_-_125348448 | 1.97 |
ENST00000339570.5
|
SCARB1
|
scavenger receptor class B, member 1 |
chr1_+_43824577 | 1.95 |
ENST00000310955.6
|
CDC20
|
cell division cycle 20 |
chr8_-_124428569 | 1.94 |
ENST00000521903.1
|
ATAD2
|
ATPase family, AAA domain containing 2 |
chr19_-_10679644 | 1.94 |
ENST00000393599.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
chr14_+_21538517 | 1.94 |
ENST00000298693.3
|
ARHGEF40
|
Rho guanine nucleotide exchange factor (GEF) 40 |
chr11_-_19263145 | 1.94 |
ENST00000532666.1
ENST00000527884.1 |
E2F8
|
E2F transcription factor 8 |
chr10_-_25241499 | 1.93 |
ENST00000376378.1
ENST00000376376.3 ENST00000320152.6 |
PRTFDC1
|
phosphoribosyl transferase domain containing 1 |
chr10_-_103535657 | 1.92 |
ENST00000344255.3
ENST00000320185.2 ENST00000346714.3 ENST00000347978.2 |
FGF8
|
fibroblast growth factor 8 (androgen-induced) |
chr2_-_72375167 | 1.91 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr6_-_33714667 | 1.88 |
ENST00000293756.4
|
IP6K3
|
inositol hexakisphosphate kinase 3 |
chr19_-_14201776 | 1.88 |
ENST00000269724.5
|
SAMD1
|
sterile alpha motif domain containing 1 |
chr10_+_35415851 | 1.87 |
ENST00000374726.3
|
CREM
|
cAMP responsive element modulator |
chr19_-_10679697 | 1.87 |
ENST00000335766.2
|
CDKN2D
|
cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4) |
chr15_-_34659349 | 1.87 |
ENST00000314891.6
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
chr19_-_2015699 | 1.86 |
ENST00000255608.4
|
BTBD2
|
BTB (POZ) domain containing 2 |
chr4_+_1873100 | 1.85 |
ENST00000508803.1
|
WHSC1
|
Wolf-Hirschhorn syndrome candidate 1 |
chr8_+_124429006 | 1.85 |
ENST00000522194.1
ENST00000523356.1 |
WDYHV1
|
WDYHV motif containing 1 |
chr19_-_15344243 | 1.83 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
chr10_+_94833642 | 1.83 |
ENST00000224356.4
ENST00000394139.1 |
CYP26A1
|
cytochrome P450, family 26, subfamily A, polypeptide 1 |
chr2_-_241396106 | 1.83 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
chr10_-_15210615 | 1.82 |
ENST00000378150.1
|
NMT2
|
N-myristoyltransferase 2 |
chr19_+_11201275 | 1.81 |
ENST00000252444.5
|
LDLR
|
low density lipoprotein receptor |
chr9_+_138606400 | 1.80 |
ENST00000486577.2
|
KCNT1
|
potassium channel, subfamily T, member 1 |
chr13_+_110959598 | 1.80 |
ENST00000360467.5
|
COL4A2
|
collagen, type IV, alpha 2 |
chr9_-_136223324 | 1.80 |
ENST00000371974.3
|
SURF1
|
surfeit 1 |
chr9_+_139847347 | 1.80 |
ENST00000371632.3
|
LCN12
|
lipocalin 12 |
chr8_+_86376081 | 1.79 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
chr16_-_89787360 | 1.78 |
ENST00000389386.3
|
VPS9D1
|
VPS9 domain containing 1 |
chr18_+_77155856 | 1.78 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr7_+_100797726 | 1.78 |
ENST00000429457.1
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
chr1_+_43824669 | 1.77 |
ENST00000372462.1
|
CDC20
|
cell division cycle 20 |
chr11_-_93276582 | 1.77 |
ENST00000298966.2
|
SMCO4
|
single-pass membrane protein with coiled-coil domains 4 |
chr19_-_51472031 | 1.76 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr22_-_37915535 | 1.75 |
ENST00000403299.1
|
CARD10
|
caspase recruitment domain family, member 10 |
chr18_+_33877654 | 1.75 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
chr6_+_37137939 | 1.73 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
chr9_-_139891165 | 1.72 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
chr10_+_131265443 | 1.72 |
ENST00000306010.7
|
MGMT
|
O-6-methylguanine-DNA methyltransferase |
chr5_+_170288856 | 1.70 |
ENST00000523189.1
|
RANBP17
|
RAN binding protein 17 |
chr7_-_148581251 | 1.68 |
ENST00000478654.1
ENST00000460911.1 ENST00000350995.2 |
EZH2
|
enhancer of zeste homolog 2 (Drosophila) |
chr11_-_2170786 | 1.64 |
ENST00000300632.5
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr1_-_29450399 | 1.64 |
ENST00000521452.1
|
TMEM200B
|
transmembrane protein 200B |
chr15_-_91537723 | 1.62 |
ENST00000394249.3
ENST00000559811.1 ENST00000442656.2 ENST00000557905.1 ENST00000361919.3 |
PRC1
|
protein regulator of cytokinesis 1 |
chr18_+_5238055 | 1.62 |
ENST00000582363.1
ENST00000582008.1 ENST00000580082.1 |
LINC00667
|
long intergenic non-protein coding RNA 667 |
chr5_-_146833485 | 1.61 |
ENST00000398514.3
|
DPYSL3
|
dihydropyrimidinase-like 3 |
chrX_-_152939133 | 1.61 |
ENST00000370150.1
|
PNCK
|
pregnancy up-regulated nonubiquitous CaM kinase |
chr8_+_143761874 | 1.61 |
ENST00000301258.4
ENST00000513264.1 |
PSCA
|
prostate stem cell antigen |
chr7_-_149470540 | 1.61 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
chr5_-_60140089 | 1.61 |
ENST00000507047.1
ENST00000438340.1 ENST00000425382.1 ENST00000508821.1 |
ELOVL7
|
ELOVL fatty acid elongase 7 |
chr10_+_81466084 | 1.60 |
ENST00000342531.2
|
NUTM2B
|
NUT family member 2B |
chr7_-_143059845 | 1.60 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr7_+_155089486 | 1.60 |
ENST00000340368.4
ENST00000344756.4 ENST00000425172.1 ENST00000342407.5 |
INSIG1
|
insulin induced gene 1 |
chr19_-_39226045 | 1.60 |
ENST00000597987.1
ENST00000595177.1 |
CAPN12
|
calpain 12 |
chr9_+_35829208 | 1.60 |
ENST00000439587.2
ENST00000377991.4 |
TMEM8B
|
transmembrane protein 8B |
chr14_-_92302825 | 1.60 |
ENST00000556018.1
|
TC2N
|
tandem C2 domains, nuclear |
chr16_+_89894875 | 1.60 |
ENST00000393062.2
|
SPIRE2
|
spire-type actin nucleation factor 2 |
chr19_-_49258606 | 1.59 |
ENST00000310160.3
|
FUT1
|
fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group) |
chr19_-_55658650 | 1.59 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr11_-_61582579 | 1.58 |
ENST00000539419.1
ENST00000545245.1 ENST00000545405.1 ENST00000542506.1 |
FADS1
|
fatty acid desaturase 1 |
chr12_-_124018252 | 1.58 |
ENST00000376874.4
|
RILPL1
|
Rab interacting lysosomal protein-like 1 |
chr19_+_45281118 | 1.58 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
chrX_+_150151824 | 1.58 |
ENST00000455596.1
ENST00000448905.2 |
HMGB3
|
high mobility group box 3 |
chr12_-_49182783 | 1.58 |
ENST00000550422.1
|
ADCY6
|
adenylate cyclase 6 |
chr20_+_44637526 | 1.57 |
ENST00000372330.3
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
chr18_+_9334755 | 1.57 |
ENST00000262120.5
|
TWSG1
|
twisted gastrulation BMP signaling modulator 1 |
chr1_+_3689325 | 1.56 |
ENST00000444870.2
ENST00000452264.1 |
SMIM1
|
small integral membrane protein 1 (Vel blood group) |
chr17_-_34122596 | 1.56 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
chr3_+_160117418 | 1.56 |
ENST00000465903.1
ENST00000485645.1 ENST00000360111.2 ENST00000472991.1 ENST00000467468.1 ENST00000469762.1 ENST00000489573.1 ENST00000462787.1 ENST00000490207.1 ENST00000485867.1 |
SMC4
|
structural maintenance of chromosomes 4 |
chr11_+_46402744 | 1.55 |
ENST00000533952.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr7_-_149470297 | 1.55 |
ENST00000484747.1
|
ZNF467
|
zinc finger protein 467 |
chr15_+_41624892 | 1.55 |
ENST00000260359.6
ENST00000450318.1 ENST00000450592.2 ENST00000559596.1 ENST00000414849.2 ENST00000560747.1 ENST00000560177.1 |
NUSAP1
|
nucleolar and spindle associated protein 1 |
chr11_+_66624527 | 1.54 |
ENST00000393952.3
|
LRFN4
|
leucine rich repeat and fibronectin type III domain containing 4 |
chr20_-_52210368 | 1.54 |
ENST00000371471.2
|
ZNF217
|
zinc finger protein 217 |
chr7_+_65670186 | 1.54 |
ENST00000304842.5
ENST00000442120.1 |
TPST1
|
tyrosylprotein sulfotransferase 1 |
chr11_-_2906979 | 1.54 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr11_-_105948040 | 1.53 |
ENST00000534815.1
|
KBTBD3
|
kelch repeat and BTB (POZ) domain containing 3 |
chr10_-_135171510 | 1.53 |
ENST00000278025.4
ENST00000368552.3 |
FUOM
|
fucose mutarotase |
chr19_-_291365 | 1.53 |
ENST00000591572.1
ENST00000269812.3 ENST00000434325.2 |
PPAP2C
|
phosphatidic acid phosphatase type 2C |
chr5_-_127873659 | 1.53 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
chr19_-_46000251 | 1.53 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
chr2_+_10262857 | 1.52 |
ENST00000304567.5
|
RRM2
|
ribonucleotide reductase M2 |
chr20_+_62694834 | 1.52 |
ENST00000415602.1
|
TCEA2
|
transcription elongation factor A (SII), 2 |
chr21_+_40177755 | 1.52 |
ENST00000360938.3
ENST00000432278.1 |
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
chr3_-_16555150 | 1.52 |
ENST00000334133.4
|
RFTN1
|
raftlin, lipid raft linker 1 |
chr7_+_192969 | 1.52 |
ENST00000313766.5
|
FAM20C
|
family with sequence similarity 20, member C |
chr8_-_143867946 | 1.51 |
ENST00000301263.4
|
LY6D
|
lymphocyte antigen 6 complex, locus D |
chr2_-_160143242 | 1.51 |
ENST00000359774.4
|
WDSUB1
|
WD repeat, sterile alpha motif and U-box domain containing 1 |
chr1_-_6453426 | 1.51 |
ENST00000545482.1
|
ACOT7
|
acyl-CoA thioesterase 7 |
chr22_+_51112800 | 1.51 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr20_+_62371206 | 1.51 |
ENST00000266077.2
|
SLC2A4RG
|
SLC2A4 regulator |
chr2_-_215674374 | 1.51 |
ENST00000449967.2
ENST00000421162.1 ENST00000260947.4 |
BARD1
|
BRCA1 associated RING domain 1 |
chr2_-_160143084 | 1.50 |
ENST00000409990.3
|
WDSUB1
|
WD repeat, sterile alpha motif and U-box domain containing 1 |
chr11_+_13690249 | 1.50 |
ENST00000532701.1
|
FAR1
|
fatty acyl CoA reductase 1 |
chr3_-_43663389 | 1.50 |
ENST00000444344.1
ENST00000456438.1 ENST00000350459.4 ENST00000396091.3 ENST00000451430.2 ENST00000428472.1 ENST00000414522.2 |
ANO10
|
anoctamin 10 |
chr19_-_51504411 | 1.50 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
chr8_-_10588010 | 1.50 |
ENST00000304501.1
|
SOX7
|
SRY (sex determining region Y)-box 7 |
chr10_-_15210666 | 1.49 |
ENST00000378165.4
|
NMT2
|
N-myristoyltransferase 2 |
chr20_+_43374421 | 1.49 |
ENST00000372861.3
|
KCNK15
|
potassium channel, subfamily K, member 15 |
chr20_-_22565101 | 1.49 |
ENST00000419308.2
|
FOXA2
|
forkhead box A2 |
chr9_+_133971863 | 1.48 |
ENST00000372309.3
|
AIF1L
|
allograft inflammatory factor 1-like |
chr6_+_3000218 | 1.48 |
ENST00000380441.1
ENST00000380455.4 ENST00000380454.4 |
NQO2
|
NAD(P)H dehydrogenase, quinone 2 |
chr17_+_80709932 | 1.48 |
ENST00000355528.4
ENST00000397466.2 ENST00000539345.2 |
TBCD
|
tubulin folding cofactor D |
chr4_+_17812525 | 1.48 |
ENST00000251496.2
|
NCAPG
|
non-SMC condensin I complex, subunit G |
chr2_-_95825352 | 1.48 |
ENST00000295208.2
|
ZNF514
|
zinc finger protein 514 |
chr16_+_77246337 | 1.47 |
ENST00000563157.1
|
SYCE1L
|
synaptonemal complex central element protein 1-like |
chr3_-_43663519 | 1.47 |
ENST00000427171.1
ENST00000292246.3 |
ANO10
|
anoctamin 10 |
chr17_-_66453562 | 1.47 |
ENST00000262139.5
ENST00000546360.1 |
WIPI1
|
WD repeat domain, phosphoinositide interacting 1 |
chr8_+_26371763 | 1.47 |
ENST00000521913.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
chr4_-_99579733 | 1.46 |
ENST00000305798.3
|
TSPAN5
|
tetraspanin 5 |
chr7_+_36429424 | 1.46 |
ENST00000396068.2
|
ANLN
|
anillin, actin binding protein |
chr1_+_37940153 | 1.46 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
chr4_+_75310851 | 1.46 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
chr19_-_55658281 | 1.45 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr5_+_153570319 | 1.45 |
ENST00000377661.2
|
GALNT10
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10) |
chr19_+_6531010 | 1.45 |
ENST00000245817.3
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9 |
chr16_-_85784557 | 1.45 |
ENST00000602675.1
|
C16orf74
|
chromosome 16 open reading frame 74 |
chr7_-_65447192 | 1.45 |
ENST00000421103.1
ENST00000345660.6 ENST00000304895.4 |
GUSB
|
glucuronidase, beta |
chr19_-_40971667 | 1.44 |
ENST00000263368.4
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr20_-_43280325 | 1.44 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
chr2_-_160143158 | 1.44 |
ENST00000409124.1
ENST00000358147.4 |
WDSUB1
|
WD repeat, sterile alpha motif and U-box domain containing 1 |
chr7_-_156685890 | 1.44 |
ENST00000353442.5
|
LMBR1
|
limb development membrane protein 1 |
chr1_-_9189229 | 1.44 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
chr19_-_55919087 | 1.44 |
ENST00000587845.1
ENST00000589978.1 ENST00000264552.9 |
UBE2S
|
ubiquitin-conjugating enzyme E2S |
chr17_+_7155819 | 1.44 |
ENST00000570322.1
ENST00000576496.1 ENST00000574841.2 |
ELP5
|
elongator acetyltransferase complex subunit 5 |
chr7_+_36429409 | 1.43 |
ENST00000265748.2
|
ANLN
|
anillin, actin binding protein |
chr6_-_99797522 | 1.43 |
ENST00000389677.5
|
FAXC
|
failed axon connections homolog (Drosophila) |
chr17_+_76210367 | 1.43 |
ENST00000592734.1
ENST00000587746.1 |
BIRC5
|
baculoviral IAP repeat containing 5 |
chr11_+_2923423 | 1.42 |
ENST00000312221.5
|
SLC22A18
|
solute carrier family 22, member 18 |
chr3_+_121554046 | 1.42 |
ENST00000273668.2
ENST00000451944.2 |
EAF2
|
ELL associated factor 2 |
chr11_+_46402583 | 1.42 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chrY_-_297445 | 1.42 |
ENSTR0000390665.3
|
PPP2R3B
|
protein phosphatase 2, regulatory subunit B'', beta |
chr19_-_40971643 | 1.41 |
ENST00000595483.1
|
BLVRB
|
biliverdin reductase B (flavin reductase (NADPH)) |
chr18_+_657578 | 1.41 |
ENST00000323274.10
|
TYMS
|
thymidylate synthetase |
chr11_+_76778033 | 1.41 |
ENST00000456580.2
|
CAPN5
|
calpain 5 |
chr5_-_171881491 | 1.41 |
ENST00000311601.5
|
SH3PXD2B
|
SH3 and PX domains 2B |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
2.3 | 9.3 | GO:0009447 | putrescine catabolic process(GO:0009447) |
1.7 | 5.2 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
1.3 | 4.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
1.2 | 4.9 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
1.2 | 3.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
1.2 | 3.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
1.2 | 6.9 | GO:0030421 | defecation(GO:0030421) |
1.1 | 1.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
1.1 | 6.9 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.1 | 3.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
1.1 | 10.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.0 | 4.1 | GO:0046104 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.0 | 4.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
1.0 | 4.0 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.0 | 2.9 | GO:2000775 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
1.0 | 2.9 | GO:1904172 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
0.9 | 2.8 | GO:0042938 | dipeptide transport(GO:0042938) |
0.9 | 2.8 | GO:0019860 | uracil metabolic process(GO:0019860) |
0.9 | 2.8 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.9 | 3.6 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.9 | 2.7 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.9 | 0.9 | GO:0097102 | endothelial tip cell fate specification(GO:0097102) |
0.9 | 2.6 | GO:0071810 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
0.9 | 3.5 | GO:0036114 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.9 | 2.6 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.8 | 2.5 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
0.8 | 5.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.8 | 2.5 | GO:0097187 | dentinogenesis(GO:0097187) |
0.8 | 2.4 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.8 | 2.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.8 | 3.1 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
0.8 | 3.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.8 | 3.0 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.8 | 2.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.8 | 2.3 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.7 | 6.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.7 | 2.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.7 | 3.3 | GO:1905071 | occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.6 | 1.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.6 | 2.6 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.6 | 8.4 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.6 | 5.1 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.6 | 1.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.6 | 4.4 | GO:0016129 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
0.6 | 1.8 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.6 | 3.6 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.6 | 0.6 | GO:0003213 | cardiac right atrium morphogenesis(GO:0003213) |
0.6 | 1.8 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.6 | 1.7 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.6 | 5.2 | GO:0019367 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.6 | 1.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
0.6 | 2.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.5 | 0.5 | GO:0045736 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.5 | 3.3 | GO:0060717 | chorion development(GO:0060717) |
0.5 | 0.5 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.5 | 4.3 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.5 | 3.2 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.5 | 1.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.5 | 4.2 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
0.5 | 2.1 | GO:0019427 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
0.5 | 0.5 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.5 | 2.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.5 | 1.5 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
0.5 | 0.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 2.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 1.5 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.5 | 0.5 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.5 | 2.0 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.5 | 2.0 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
0.5 | 2.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.5 | 2.5 | GO:0015862 | uridine transport(GO:0015862) |
0.5 | 8.3 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
0.5 | 1.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.5 | 0.5 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.5 | 1.9 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
0.5 | 0.5 | GO:2001037 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
0.5 | 0.9 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.5 | 0.5 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.5 | 2.8 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.5 | 1.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.5 | 2.3 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
0.5 | 1.4 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.5 | 1.4 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 1.8 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
0.5 | 0.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.4 | 3.6 | GO:0046618 | drug export(GO:0046618) |
0.4 | 1.3 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
0.4 | 2.2 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
0.4 | 2.6 | GO:0043585 | nose morphogenesis(GO:0043585) |
0.4 | 4.0 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 2.6 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 0.9 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) long-chain fatty acid catabolic process(GO:0042758) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.4 | 1.7 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.4 | 0.4 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.4 | 1.3 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 1.7 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.4 | 1.7 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 5.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.4 | 3.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.4 | 1.7 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.4 | 1.6 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.4 | 4.9 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.4 | 1.2 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.4 | 6.1 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 1.2 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.4 | 4.8 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 4.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.4 | 1.2 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.4 | 1.6 | GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.4 | 2.0 | GO:0019075 | virus maturation(GO:0019075) |
0.4 | 1.2 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.4 | 2.3 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.4 | 2.7 | GO:0060992 | response to fungicide(GO:0060992) |
0.4 | 4.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.4 | 1.9 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.4 | 1.5 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.4 | 1.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 2.7 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 1.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
0.4 | 1.1 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.4 | 1.1 | GO:0090135 | actin filament branching(GO:0090135) |
0.4 | 1.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.4 | 2.6 | GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway(GO:0010641) |
0.4 | 1.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.4 | 1.8 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 1.1 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.4 | 1.1 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.4 | 1.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.4 | 2.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.4 | 1.1 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
0.4 | 0.7 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.4 | 2.1 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.4 | 1.8 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.4 | 1.1 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 1.8 | GO:0060356 | leucine import(GO:0060356) |
0.4 | 1.1 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.4 | 0.4 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
0.4 | 1.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.4 | 3.2 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.3 | 1.0 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.3 | 3.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.3 | 1.4 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.3 | 1.0 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.3 | 2.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.3 | 1.0 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.3 | 1.0 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.3 | 1.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.3 | 0.7 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 1.0 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
0.3 | 1.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.3 | 1.3 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 3.0 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
0.3 | 2.0 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.3 | 3.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 1.3 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.3 | 1.0 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.3 | 1.0 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
0.3 | 1.0 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 2.0 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 2.3 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.3 | 0.7 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.3 | 1.0 | GO:1903925 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.3 | 2.9 | GO:0051383 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.3 | 1.0 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.3 | 0.7 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 1.0 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 1.6 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.3 | 0.3 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.3 | 2.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.3 | 2.6 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.3 | 0.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 0.3 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 2.2 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.3 | 2.5 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.3 | 1.3 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.3 | 0.9 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.3 | 0.6 | GO:0051665 | membrane raft localization(GO:0051665) |
0.3 | 1.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.3 | 0.9 | GO:0071529 | cementum mineralization(GO:0071529) |
0.3 | 1.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.3 | 1.9 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.3 | 0.9 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.3 | 0.3 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.3 | 2.2 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.3 | 6.8 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.3 | 4.3 | GO:0060346 | bone trabecula formation(GO:0060346) |
0.3 | 1.8 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.3 | 2.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.9 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.3 | 3.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 1.5 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.3 | 0.3 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
0.3 | 0.6 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 0.9 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 0.3 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
0.3 | 1.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 0.9 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.3 | 0.3 | GO:0032680 | regulation of tumor necrosis factor production(GO:0032680) |
0.3 | 2.1 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.3 | 0.9 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
0.3 | 7.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 0.6 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.3 | 1.8 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
0.3 | 0.9 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.3 | 1.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 2.0 | GO:1904779 | regulation of protein localization to centrosome(GO:1904779) |
0.3 | 2.0 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.3 | 0.9 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.3 | 0.9 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.3 | 0.6 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 0.9 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.3 | 1.4 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
0.3 | 1.2 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 0.6 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.3 | 0.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 3.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 4.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.3 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
0.3 | 0.3 | GO:0070444 | oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
0.3 | 0.8 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.1 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.3 | 2.8 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.3 | 1.1 | GO:1901675 | negative regulation of histone H3-K27 acetylation(GO:1901675) |
0.3 | 1.1 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.3 | 1.7 | GO:0007498 | mesoderm development(GO:0007498) |
0.3 | 0.8 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.3 | 0.8 | GO:1902081 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.3 | 0.8 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.3 | 0.6 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.3 | 1.1 | GO:0044334 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.3 | 0.8 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.3 | 1.1 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
0.3 | 3.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.3 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.3 | 1.9 | GO:0070649 | polar body extrusion after meiotic divisions(GO:0040038) formin-nucleated actin cable assembly(GO:0070649) |
0.3 | 0.8 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.3 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 0.8 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.3 | 1.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.3 | 5.8 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.3 | 0.8 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
0.3 | 5.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 0.5 | GO:0090182 | regulation of secretion of lysosomal enzymes(GO:0090182) |
0.3 | 0.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.3 | 1.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.3 | 1.1 | GO:0042853 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
0.3 | 1.3 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.3 | 1.6 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
0.3 | 0.3 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.3 | 0.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.3 | 1.3 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.3 | 1.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.3 | 0.3 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 0.8 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.3 | 1.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.3 | 0.3 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.3 | 3.1 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.3 | 0.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.3 | 0.8 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.3 | 1.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.3 | 1.5 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.3 | 1.8 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 0.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.0 | GO:0071455 | cellular response to hyperoxia(GO:0071455) |
0.3 | 0.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.3 | 1.3 | GO:0051946 | regulation of amino acid uptake involved in synaptic transmission(GO:0051941) regulation of glutamate uptake involved in transmission of nerve impulse(GO:0051946) regulation of L-glutamate import(GO:1900920) |
0.3 | 1.8 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
0.3 | 1.3 | GO:1904744 | regulation of telomeric DNA binding(GO:1904742) positive regulation of telomeric DNA binding(GO:1904744) |
0.3 | 0.5 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 1.7 | GO:0006868 | glutamine transport(GO:0006868) |
0.2 | 1.2 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 1.7 | GO:1902510 | regulation of apoptotic DNA fragmentation(GO:1902510) |
0.2 | 0.7 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.2 | 1.0 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.2 | 1.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 3.2 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 1.5 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 2.9 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 1.0 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.2 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 0.2 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.2 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.2 | 3.6 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.2 | 1.4 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
0.2 | 0.2 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.2 | 1.2 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.2 | 1.0 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.7 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 3.5 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.2 | 3.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.5 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.2 | 0.9 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.2 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.2 | 6.0 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 0.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.2 | 0.7 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.2 | 2.1 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.2 | 0.2 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.2 | 0.7 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.2 | 0.9 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.2 | 0.5 | GO:0060998 | regulation of dendritic spine development(GO:0060998) |
0.2 | 1.8 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 0.2 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.2 | 1.6 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.2 | 0.7 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.2 | 2.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 1.8 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.2 | 0.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.2 | 0.2 | GO:0036090 | cleavage furrow ingression(GO:0036090) |
0.2 | 0.2 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.2 | 0.9 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.2 | 0.9 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.2 | 1.3 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.2 | 0.4 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.2 | 0.2 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
0.2 | 0.2 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 2.0 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.2 | 2.7 | GO:0051231 | spindle elongation(GO:0051231) |
0.2 | 5.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 1.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 0.7 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.2 | 4.4 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 0.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.2 | 0.4 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.2 | 1.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.2 | 3.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 0.9 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 1.9 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.2 | 4.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 2.8 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.2 | 0.6 | GO:0061536 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 2.6 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.2 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 0.9 | GO:0009386 | translational attenuation(GO:0009386) |
0.2 | 0.4 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 3.9 | GO:0051608 | histamine transport(GO:0051608) |
0.2 | 0.4 | GO:2000412 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
0.2 | 0.2 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.2 | 0.4 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 9.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.2 | 1.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.6 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 0.2 | GO:0036065 | fucosylation(GO:0036065) |
0.2 | 0.2 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.2 | 0.6 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
0.2 | 1.5 | GO:0070305 | response to cGMP(GO:0070305) |
0.2 | 1.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.2 | 0.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.2 | 0.8 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.2 | 0.2 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
0.2 | 2.7 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.2 | 11.0 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.2 | 3.1 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.2 | 2.1 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
0.2 | 0.4 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.2 | 0.8 | GO:0010266 | response to vitamin B1(GO:0010266) |
0.2 | 1.4 | GO:0007135 | meiosis II(GO:0007135) |
0.2 | 1.0 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.2 | 0.2 | GO:0036216 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.2 | 1.8 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) |
0.2 | 0.4 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.2 | 1.8 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.2 | 0.4 | GO:0060214 | endocardium formation(GO:0060214) |
0.2 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 0.6 | GO:0003157 | endocardium development(GO:0003157) |
0.2 | 0.4 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 1.8 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.2 | 1.0 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.2 | 0.6 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.2 | 2.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.2 | 0.8 | GO:0006726 | eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
0.2 | 2.2 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 0.6 | GO:0006272 | leading strand elongation(GO:0006272) |
0.2 | 0.8 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 0.2 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 1.0 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.2 | 0.4 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.2 | 0.2 | GO:0010332 | response to gamma radiation(GO:0010332) |
0.2 | 1.8 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.2 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.2 | 0.6 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.2 | 3.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 1.4 | GO:0021564 | vagus nerve development(GO:0021564) |
0.2 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.2 | 1.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 0.8 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
0.2 | 1.0 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.2 | 2.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.2 | 1.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 2.9 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.2 | 0.2 | GO:1902527 | regulation of protein monoubiquitination(GO:1902525) positive regulation of protein monoubiquitination(GO:1902527) |
0.2 | 1.8 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 1.4 | GO:0097338 | response to clozapine(GO:0097338) |
0.2 | 1.0 | GO:1902228 | mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
0.2 | 0.8 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.2 | 2.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.2 | 0.6 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.8 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
0.2 | 0.6 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.2 | 0.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.2 | 1.3 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 1.0 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.2 | 0.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
0.2 | 1.5 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.2 | 0.2 | GO:0003032 | detection of oxygen(GO:0003032) |
0.2 | 1.5 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.2 | 1.5 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.2 | 13.8 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 0.8 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.2 | 0.8 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.2 | 0.2 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.2 | 0.2 | GO:0061511 | centriole elongation(GO:0061511) |
0.2 | 0.2 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.2 | 0.6 | GO:0035690 | cellular response to drug(GO:0035690) |
0.2 | 1.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.2 | 1.5 | GO:0034141 | positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
0.2 | 0.6 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.2 | 1.1 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 0.4 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.7 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.2 | 1.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.9 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.2 | 5.3 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.2 | 0.2 | GO:2001303 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.2 | 2.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 2.0 | GO:0070257 | positive regulation of mucus sec |